US Broker Ratings

Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a Potential 247.90% Upside in the Biotechnology Space

For investors with a keen eye on the biotechnology sector, Vaxcyte, Inc. (PCVX) is emerging as a compelling opportunity. With its current market cap standing at..

Verona Pharma plc (VRNA) Stock Analysis: Evaluating the Growth Potential in Biotech with a $9 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a pioneering force in the biotechnology sector, is making waves in the healthcare industry with its innovative approach to treating respiratory..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unpacking a 11.38% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a notable player in the healthcare sector, particularly within the medical instruments and supplies industry, presents an intriguing opportunity for..

Cytokinetics, Incorporated (CYTK) Stock Analysis: 40% Potential Upside with Robust Pipeline

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the healthcare sector, particularly in the biotechnology industry, is making waves in the market with a current market..

Avidity Biosciences, Inc. (RNA): Analyst Consensus and Growth Potential with a 33% Upside

Avidity Biosciences, Inc. (NASDAQ: RNA) stands out in the biotechnology sector with a promising outlook for investors. As a pioneering player in the field of RNA..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Promising 69.99% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO) has caught the attention of investors with its compelling potential upside of 69.99%. As a clinical-stage biopharmaceutical company, Soleno is making..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating a Promising Yet Volatile Biotech Landscape

Blueprint Medicines Corporation (NASDAQ: BPMC) operates within the dynamic biotechnology sector, with a focus on precision therapies targeting genomically defined cancers and blood disorders. Headquartered in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Is the Biotech’s Impressive 40.8% Revenue Growth a Game Changer?

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is attracting substantial attention in the biotechnology sector, riding high on a robust revenue growth of 40.8%. This San Diego-based biopharmaceutical..

Exelixis, Inc. (EXEL) Stock Analysis: A 16.3% Potential Upside in Oncology Biotech

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has made a name for itself with its focus on developing groundbreaking treatments for challenging..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 33% Potential Upside in the Medical Devices Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is capturing the attention of investors with its innovative approach to organ transplant therapy, poised for significant growth in the burgeoning..

Axsome Therapeutics (AXSM) Stock Analysis: A Promising 41% Upside in the Booming CNS Market

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a frontrunner in the development of novel therapies for central nervous system (CNS) disorders, is capturing investor attention with a compelling..

AptarGroup, Inc. (ATR) Stock Analysis: Unveiling a 28.72% Potential Upside for Investors

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector under the medical instruments and supplies industry, commands significant attention with its $9.13 billion market..

Nuvalent, Inc. (NUVL) Stock Analysis: A Biotech Gem with a 45% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, has captured the attention of investors with its promising pipeline of cancer therapies. Specializing..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 69% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out in the biotechnology industry with a notable potential upside of 69.64%, according to the latest analyst ratings. This figure..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 52-Week High with Strategic Insights

Medpace Holdings, Inc. (NASDAQ: MEDP) is currently catching the eye of investors, as its stock price has reached the upper limit of its 52-week range, peaking..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Growth Story with 8.43% Potential Upside

RadNet, Inc. (NASDAQ: RDNT), a leader in the healthcare sector, specifically within diagnostics and research, provides a compelling investment opportunity characterized by a robust growth narrative..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Assessing the 11.25% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has garnered significant attention in the biotechnology sector, particularly due to its innovative RNA-targeted medicine portfolio. With a market capitalization of..

Legend Biotech (LEGN): Investor Outlook on a Promising Biotech with Over 114% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) stands out as a compelling investment opportunity within the biotechnology sector. With a market capitalization of $6.66 billion, this healthcare company..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unveiling Potential Amidst Volatility and Strong Revenue Growth

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) continues to capture investor attention with its dynamic position in the biotechnology sector, particularly in the development of RNA-targeted therapeutics and..

The Ensign Group, Inc. (ENSG) Stock Analysis: Promising Growth in Healthcare Sector with Strong Buy Ratings

The Ensign Group, Inc. (NASDAQ: ENSG) is making remarkable strides in the healthcare sector, capturing the attention of investors with its robust financial performance and strategic..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds